Dr. David N. Lamond, DO
Family Medicine (Family Medicine Physician)
- Medicare participating
At a glance
- Medical school
- Albany Medical College of Union University (2004)
- Years since graduation
- 22
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 171
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2004Medical school: Albany Medical College of Union University
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
NC license 200400137
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Pardee Hospital Henderson County Hendersonville, NC
Medical groups
- Lamond Family Medicine PLLC (49 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 171
- Services billed
- 787
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 209 | 146 |
| Established patient office or other outpatient visit, 20-29 minutes | 152 | 88 |
| Test to measure exhaled air for evaluation of lung function at rest | 30 | 29 |
| Annual depression screening, 5 to 15 minutes | 24 | 24 |
| New patient office or other outpatient visit, 30-44 minutes | 23 | 23 |
| Testosterone (hormone) level, free | 15 | 14 |
| Testosterone (hormone) level, total | 15 | 14 |
| Insertion of needle into vein for collection of blood sample | 15 | 14 |
| Measurement of total estradiol (hormone) | 15 | 14 |
| Gonadotropin, follicle stimulating (reproductive hormone) level | 13 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 2 companies reported 11 payments worth $177 in total to this clinician.
| AbbVie Inc. | $150 |
|---|---|
| Galderma Laboratories, L.P. | $26.41 |
| Food and Beverage | $177 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $7,200 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults
Ipsen Innovation · Active, not recruiting · NCT06047444 - A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults
Ipsen Innovation · Active, not recruiting · NCT06047457 - BAY 948862, A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in partic
Bayer HealthCare Pharmaceuticals Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.